Biologic therapies and pregnancy: The story so far

Medicine and Dentistry

• Biological Therapy 100%
• Conception 100%
• Rheumatoid Arthritis 66%
• Rituximab 66%
• Tumor Necrosis Factor 66%
• Placenta 33%
• Childbirth 33%
• Anakinra 33%
• Tocilizumab 33%
• Fusion Protein 33%
• First Trimester Pregnancy 33%
• Human Milk 33%
• Third Trimester Pregnancy 33%
• Second Trimester Pregnancy 33%
• Lymphocytopenia 33%
• Inflammatory Bowel Disease 33%
• Monoclonal Antibody 33%
• Biological Product 33%
• Abatacept 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Rheumatoid Arthritis 100%
• Rituximab 100%
• Tumor Necrosis Factor 100%
• Inflammatory Bowel Disease 50%
• Monoclonal Antibody 50%
• Fusion Protein 50%
• Biological Product 50%
• Tocilizumab 50%
• Anakinra 50%
• Abatacept 50%
• Lymphocytopenia 50%

Immunology and Microbiology

• Tocilizumab 33%